Asia-Pacific
The Straits Times

Yen becoming better hedge against AI market shock: Goldman Sachs

The call comes after the yen showed renewed signs of its traditional haven characteristics during last week’s global tech stock rout. The yen is becoming a more effective hedge against an artificial intelligence-driven market shock as changes in Japan’s policy backdrop reduce the risk of the currency weakening sharply when global yields rise, according to Goldman Sachs. “The yen now looks like a more attractive hedge for pro-cyclical portfolios than it has been over recent years, despite the global backdrop still arguing for further JPY weakness,” strategists including Kamakshya Trivedi wrote in a note dated Oct 23. The call comes after the yen showed renewed signs of its traditional haven characteristics during last week’s global tech stock rout. It surged 0.9% against the US dollar on Oct 22 and briefly reached its strongest level in more than a month on Oct 23 as concerns over the AI investment boom drove equities lower and sparked a sharp Treasury rally. Goldman argues that the AI boom has left both US equities and the US dollar particularly exposed to a deterioration in the growth outlook. A shock that pushes stocks and bond yields lower at the same time would create the type of market environment that has historically been most favourable for the yen. There are also early signs that the currency is becoming less vulnerable when global yields move higher, according to Goldman. Yen weakness in response to rising yields has been more limited recently than over the past six to seven years, which the strategists said most likely reflects reduced depreciation pressure from Japan’s domestic policy settings. That marks a contrast with 2022, when the Bank of Japan maintained yield-curve control as global borrowing costs surged. The changing relationship means the yen “should be a less painful hedge to hold, even if carry remains negative”, Goldman said. A more constructive domestic policy backdrop, the yen’s cheap valuation and elevated risk of currency intervention are also helping to limit the potential dollar-yen upside, improving the asymmetry of holding the Japanese currency as a hedge.

Yen becoming better hedge against AI market shock: Goldman Sachs
Europe
BBC Business

Trump sued over Canadian tariffs in latest legal challenge

Image source, Jim Lo Scalzo/Pool/EPA/ShutterstockByRachel ClunBusiness reporter, Reporting fromNew YorkPublished8 hours agoUS President Donald Trump is facing another legal challenge on tariffs after the group that successfully sued over his so-called "liberation day" import taxes filed a new lawsuit over the latest Canadian levies. The White House imposed a 50% levy on some $20bn of Canadian goods after trade talks between the US and Canada broke down in August. The Liberty Justice Center filed a suit on behalf of US food business Gellert Global Group, urging the US Court of International Trade to find the levies unlawful and to order refunds with interest for affected importers. The lawsuit argues the White House exceeded its authority in imposing the tariffs and caused "immediate harm to American businesses". Gellert Global Group is a third-generation family business that is paying 50% tariffs on cheese exported from Canada. The New Jersey-based firm is also facing retaliatory tariffs from Canada on American-made cheese it sells north of the border. Co-chief executive Thomas Gellert said the firm had spent generations building relationships with suppliers and customers in the food industry. "These tariffs disrupt those relationships overnight and create costs and uncertainty that ripple through the entire supply chain," he said on Tuesday. The Liberty Justice Center is challenging the administration's use of Section 338 of the 1930 Tariff Act to hit Canadian goods from wine to dairy products and hockey sticks. That section of the nearly 100-year-old Act is aimed at protecting US business against foreign discrimination, but the legal group is arguing that it does not allow the executive branch "to impose sweeping tariffs or import restrictions whenever a trade dispute arises". The lawsuit seeks to challenge the White House's reliance on retaliatory tariffs imposed by Canada to justify its own duties under Section 338. Canada has imposed a series of countermeasures against numerous US tariffs. Last month, Canadian Prime Minister Mark Carney matched the Section 338 US tariffs "dollar for dollar" after Trump imposed them for what he called "unequal treatment" of US cars, dairy and alcohol. It also points out Section 338 requires a 30-day waiting period before levies can be imposed, but the tariff on products including cheese was added to the list just a week before tariff collection began.

Trump sued over Canadian tariffs in latest legal challenge
Asia
The Hindu BusinessLine

Q2 Results Today Live: NTPC, Muthoot Finance, Shyam Metalics & Energy, Sarda Energy and Minerals, Zen Technologies, National Securities Depository, Rainbow Childrens Medicare Share to announce Q2 results

Syrma SGS eyes $1 billion revenue next year after record Q2 FY27; strong H1 growth amid component shortages and PCB bottlenecks. Reliance reports record Q2 profit and revenue, led by O2C and Jio growth, amid resilient diversified operations and strategic investments. Reliance Industries yesterday reported its highest-ever quarterly profit and revenue for the September quarter, driven by strong performances across its energy and telecom businesses. Consolidated net profit rose 33.8 percent year on year to a record ₹29,550 crore, while revenue increased 27.8 percent to an all-time high of ₹3.62 lakh crore. EBITDA grew 23.9 percent to a record ₹62,409 crore. Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments. We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.

Q2 Results Today Live: NTPC, Muthoot Finance, Shyam Metalics & Energy, Sarda Energy and Minerals, Zen Technologies, National Securities Depository, Rainbow Childrens Medicare Share to announce Q2 results
Asia
The Hindu BusinessLine

LIC Housing Finance Q2 PAT up 11% at ₹150.7 crore

The bank’s outstanding loan portfolio increased 5% to ₹3.26 lakh crore in Q2FY27, as aginst ₹3.11 lakh crore in the year-ago period | Photo Credit: luechai LIC Housing Finance Q2FY27 net profit recorded 11% growth at ₹150.7 crore in the quarter-ended September 2027, as against ₹135 crore posted in the year-ago period. The bank’s net interest income increased just about 2% to ₹2,088 crore in the second quarter of the current fiscal, as against ₹2,038 crore in the year-ago period. The net interest margin inched down to 2.58% in the recently concluded quarter, as against 2.62%. The bank’s outstanding loan portfolio increased 5% to ₹3.26 lakh crore in Q2FY27, as against ₹3.11 lakh crore in the year-ago period. The gross non-profitable assets as a share of advances dipped to 2.05% in September 2026, as against 2.65% in the year-ago period. NNPA ratio reduced to 1.06% from 1.19% in the year-ago period Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments. We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.

LIC Housing Finance Q2 PAT up 11% at ₹150.7 crore
Japan
Nikkei Asia

Why is Japan tightening its immigration rules?

TOKYO -- Japan is increasingly becoming dependent on foreign workers, but it has long resisted calling itself an immigrant-receiving country. By the end of 2025, more than 4 million foreign nationals were living in the country. The government has expanded pathways for workers in sectors facing chronic shortages, while also tightening rules for long-term residents and permanent residency. It has capped two major work programs, raised application fees and introduced stricter requirements. That leaves Japan caught between economic need and political pressure to take a tough stance on immigration. What will these changes mean for people hoping to build a life here, and for the businesses and communities that rely on them? To discuss this, Nikkei Asia sat down with Naoko Hashimoto of International Christian University in Tokyo. We talk about whether Japan has a coherent immigration strategy, the rise of populist politics and what the government and employers need to do to help foreign residents integrate.

Why is Japan tightening its immigration rules?
Asia-Pacific
The Straits Times

Steward Leadership 25 awards honour firms that turn social, environmental challenges into growth

Past winner BlueAcres, a privately owned Singapore-based urban and sustainable farm, was recognised as a Steward Leadership 25 honouree under the Empowering Communities category. SINGAPORE – Twenty-five companies whose projects tackle environmental and social challenges while growing profitably will be honoured on Oct 28 at Hilton Singapore Orchard. The winners make up 2026’s Steward Leadership 25 (SL25) list, which is now in its fifth year. The annual award recognises 25 financially viable projects by organisations in Asia and the Pacific that demonstrate steward leadership and achieve profitable growth by addressing environmental and social challenges. It is curated by the Steward Leadership Institute (SLI), the Insead Hoffmann Institute, global advisory firm WTW and The Straits Times. While the first cohort in 2022 was largely concentrated in South-east Asia, four editions and 100 winners later, that footprint has more than doubled from 11 impact geographies to 27, stretching from Mongolia and Japan to Nepal, Sri Lanka and Iraq. SL25 does not classify winners by nationality or company. Instead, it recognises each project by the impact it creates and the places it serves, which it calls impact geographies. Winners are recognised in five impact focus areas: climate and nature; waste and circularity; empowering communities; health; and digital well-being and access. Climate and nature has been the largest category every year, with nine or 10 winners each time. Projects have ranged from sand-based energy storage in Vietnam to restoring grazing land to protect the Great Barrier Reef. The number of winners focused on waste and circularity has risen every year, from two in 2022 to five in 2025. Past winners have turned discarded materials into upcycled safety footwear, recovered critical minerals from electronic waste, and converted farm produce into nutritious powders that reduce food loss. Modelling by global professional services firm PwC suggests that extending the lifespan of materials to create a fully circular economy in the Asia-Pacific could add US$340 billion (S$435 billion) to gross domestic product and create 15 million net new jobs over a one-year period, based on 2022 economic data. Health has also gained ground, with five winners in 2025, compared with one in 2022. Their solutions ranged from on-site preventive care for workers in India to evidence-based standards that make childbirth safer.

Steward Leadership 25 awards honour firms that turn social, environmental challenges into growth
North America
CNBC Finance

Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

Novo on Tuesday said its next-generation obesity drug, CagriSema, showed 25% weight loss on average among adult women in a new analysis conducted after a late-stage trial. The Danish company said further work is needed to confirm the hypotheses of two post-study analyses. Still, the results are the latest evidence that the experimental injection can improve upon the weight loss and other benefits offered by Novo's GLP-1 drug semaglutide, the active ingredient in its blockbuster obesity shot Wegovy and diabetes counterpart Ozempic. CagriSema, a combination of semaglutide and another drug called cagrilintide that targets the amylin pathway, is expected to launch early next year. Obesity drug leaders Novo and Eli Lilly have built new treatments around amylin, which involves a hormone released in the pancreas alongside insulin that helps regulate hunger and fullness, hoping it will give them a new revenue stream beyond existing GLP-1s. In an analysis of roughly 2,300 women with obesity or who are overweight, CagriSema was associated with 25% weight loss on average at 68 weeks compared with 3% with placebo. The results are based on an ideal scenario in which all patients stayed on treatment without interruptions. A second analysis of around 1,900 women grouped by their menopausal status found that weight loss reached 26.7%, 24.8% and 23.1% in premenopausal, perimenopausal and postmenopausal women, respectively, at 68 weeks, if all patients remained on the drug. That compares with approximately 2% across menopause groups with a placebo. Across both analyses, CagriSema was linked to reductions in abdominal fat, based on waist circumference, among women overall and across menopause stages, Novo added. The results suggest that women may experience slightly more weight loss on CagriSema than a broader population of both men and women with obesity saw in the Phase 3 trial. Initial results from the study showed that CagriSema helped adults lose 22.7% of their weight on average at 68 weeks versus 2.3% in the placebo group. However, the majority of patients in the trial — around 67% of roughly 3,400 — were women. Weight gain is very common for women during menopause. Declining estrogen levels can contribute to a slowdown in metabolism, making it easier for women to gain weight and harder to maintain muscle mass. After menopause, estrogen generally remains low and does not return to previous levels. More than 86 million women in the U.S. are 40 and older, according to the U.S. Census Bureau, which are the years in which perimenopause, menopause and postmenopause occur. "Many women with obesity or overweight experience weight gain as they move through menopause, and it is important to explore investigational products such as CagriSema across the reproductive lifespan," said Michelle Skinner Moore, Novo's interim head of clinical development, medical and regulatory affairs. Wall Street has not appeared particularly excited about CagriSema, whose previous late-stage clinical trial results disappointed investors because the drug showed weight loss efficacy below their expectations. Novo, however, maintains CagriSema is effective and differentiated enough from its other drugs to draw significant demand.

Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis
Asia
The Hindu BusinessLine

Nifty reclaims 23,000 to end October on a positive note; IT and Pharma lead, midcaps bleed

Markets closed October on a firmer footing on Friday, with benchmark indices posting gains for the third consecutive session even as crude oil’s surge to multi-month highs, a global technology selloff, and deteriorating market breadth reminded investors that the recovery remains uneven. The Nifty 50 gained 0.51 per cent to close at 23,053, reclaiming the 23,000 mark for the first time in eight sessions, while the Sensex rose 0.42 per cent to 74,459.53. On a weekly basis, the Nifty ended 2 per cent higher and the Sensex gained over 1,300 points. The headline number, however, masked significant weakness beneath the surface. “The index closed higher, but nearly two and a half times as many stocks fell as rose. After Thursday’s broad rally, today’s gain was a headline, not a market,” said Sarvam Goel, Founder of Pocketful. Within the Nifty 500 universe, only 108 stocks advanced, and both the Nifty Midcap 100 and Nifty Smallcap 100 ended in the red, falling 0.93 per cent and 1.85 per cent respectively. India VIX climbed around 3 per cent to 15.6. IT, healthcare and pharma were the session’s standout sectors, drawing buying interest even as capital goods, industrials, telecom, auto, PSU banks, media and consumer durables lagged. Trent was the top Nifty gainer, rising nearly 7 per cent after strong second-quarter results and Zudio crossing the 1,000-store milestone. IndiGo also ended firmly in the green. On the losing side, Adani Ports and Shriram Finance were among the key laggards. Laurus Labs was a notable broader-market performer, rising over 7 per cent after its quarterly profit more than doubled. Crude oil remained the dominant macro concern of the session. Brent December futures surged to $117.8 a barrel, their highest level since April, while WTI advanced towards $104 a barrel — putting both benchmarks on course for gains of more than 12 per cent for October. “The reason is crude,” Goel noted, pointing to a tanker hit by explosives in the Strait of Hormuz, Iran’s rejection of Qatar’s ceasefire proposals, and reports of a senior US military commander briefing President Trump on options against Iran ahead of the November 3 midterm elections. For India, elevated crude feeds directly into inflation and keeps the RBI’s next policy move in play. Precious metals offered little refuge. Spot gold slipped below $3,970 an ounce for the first time since mid-July, while silver tumbled more than 3 per cent to around $50.4 an ounce, its lowest since November 2025. Gold and silver are now headed for monthly declines of more than 4 per cent and 16 per cent respectively, as stronger US GDP growth of 3.4 per cent and PCE inflation at 3.6 per cent year-on-year kept rate-hike expectations alive.

Nifty reclaims 23,000 to end October on a positive note; IT and Pharma lead, midcaps bleed
Europe
DW Economy

Can Germany revive its economy before the far-right AfD gains ground?

Conflicts, rising costs and Chinese competition are testing Germany's economic model like never before. Can new growth sectors create jobs and ease voters' economic fears, thereby helping contain the far-right AfD? Chancellor Friedrich Merz's government set out a high-tech agenda focusing on six priority sectors, including artificial intelligence, quantum computing and climate-neutral mobilityImage: NEURA Robotics/pexels.com/@eren-liAdvertisementGermany's export-led economic model faces unprecedented strain just as support for the far-right Alternative for Germany (AfD) party reaches a new peak.  Chinese rivals are steadily eroding the market share of major German industrial players, while persistently high energy prices, elevated labor costs and excessive red tape are adding to the structural crisis. After two years of contraction, real GDP edged up only 0.2% last year, according to the Federal Statistical Office, Destatis. Exports to China fell 9.7% in 2025, withGerman vehicle and part shipments plunging by a third. While there are signs the German economy is turning the corner, the government's latest forecast of 1.3% growth in 2026 is still modest compared with the pre-COVID boom years. The AfD is currently polling ahead of all other political parties in Germany. The country's many economic challenges have been a major factor in the right-wing populists' rise. Germany's domestic intelligence agency sees reliable indications that the AfD is right-wing extremist in its entirety. The party has vowed to put Germany back on a growth path by ending the transition to renewable energies, lowering taxes and renegotiating European Union treaties, while also reforming welfare and sharply restricting immigration. As Chancellor Friedrich Merz's coalition searches for a fresh growth strategy to fend off the rise in populist politics, the government has set out its high-tech agenda focusing on six priority sectors. These are artificial intelligence (AI), quantum computing, microelectronics, biotechnology, clean energy (including nuclear fusion) and climate-neutral mobility.  Irene Bertschek, head of the Digital Economy research unit at the Leibniz Center for European Economic Research (ZEW), argues that Germany's research in these "key enabling technologies is very strong, particularly in the area of climate-neutral technologies." Yet, the results are often commercialized abroad, Bertschek told DW, with the United States leading in AI and China closing the gap quickly.

Can Germany revive its economy before the far-right AfD gains ground?